Page 14 - Discover Top Biotechnology Partners From Poland - Business Catalogue

Polish Biotechnology Sector Polish Biotechnology Sector

COMPANY NAME: Genomtec S.A. COMPANY NAME: genXone S.A.

WEBSITE : https://www.genomtec.com WEBSITE : https://www.genxone.eu
YEAR OF ESTABLISHMENT: 2016 YEAR OF ESTABLISHMENT: 2016
NUMBER OF EMPLOYEES: 20 NUMBER OF EMPLOYEES: 24
CERTIFICATIONS: The company has EU CE-IVD certification for the Genomtec ID RP5-PLEX CERTIFICATIONS: ISO 9001:2015, Oxford Nanopore Technologies Certification
diagnostic panel and ISO 13485.
PRODUCTS: 1. Genomtec ID: Point-of-care Molecular tetsing Analyzer PRODUCTS: Gut microbiome test NANOBIOME; Whole Genome Sequencing; Whole
2. Genomtec ID RP 5-Plex: A microfluidic lab-on-a-chip technology that Plasmid Sequencing; Metagenomic Sequencing; 16S and/or ITS Gene
rapidly identifies most common respiratory pathogens causing Sequencing; Bioinformatics; Bespoke Analysis; SARS-CoV-2 genome
infectious diseases. Sequencing; Molecular diagnostics; Clinical Trials; Tick analysis;

FORM OF COOPERATION: Trade and distribution, Joint Venture, Investment FORM OF COOPERATION: Trade and distribution

Genomtec is a Molecular Diagnostics venture committed to
introducing a fast mobile point of care testing platform with genXone address their offer to: scientific sector
the ardor to decentralize current laboratory testing (sequencing services for R&D projects, eg. WGS, 16s/ITS,
practices. Company has ready to scale SNAAT isothermal whole plasmid sequencing, microbiomes of various
technology. The company is looking for global partners enviroments), FMCG sector and epidemiological
interested in further developing the technology and its supervision (microbiological monitoring) and medicine
implementation in applications within infectious diseases or (clinical trials, diagnostics, genetic disorder test). The main
oncology based companion diagnostics. The Genomtec project is the NANOBIOME test based on sequencing of gut
technology is protected by 10 patents granted in Europe, microbiome. genXone operates globally.
the USA and Japan, and over 20 patent pending
applications in global markets.